Quris-AI Acquires Nortis
29. Oktober 2024 07:00 ET
|
Quris Technologies
BOSTON and TEL AVIV, Israel, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Quris-AI (Quris), a leading Bio-AI company focused on revolutionizing the pharmaceutical drug development process, today announced the...
Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
04. Januar 2024 08:00 ET
|
Quris Technologies
Former Biogen CEO Michel Vounatsos Joins Quris-AI Board; Yossi Ben Amram Appointed President as BioAI Innovator Continues to Expand
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
28. September 2023 08:00 ET
|
Quris Technologies
Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
Quris-AI Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
02. März 2023 07:00 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- Quris-AI, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s...
Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
20. Dezember 2022 08:00 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has secured an additional $9...
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
10. Februar 2022 00:00 ET
|
Quris Technologies
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with...